
Mesothelin - Wikipedia
Mesothelin, also known as MSLN, is a protein that in humans is encoded by the MSLN gene. [5] [6]
Mesothelin Expression in Human Tumors: A Tissue Microarray …
Apr 7, 2021 · Mesothelin (MSLN) represents an attractive molecule for targeted cancer therapies. To identify tumors that might benefit from such therapies, tissue microarrays including 15,050 …
Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
The MSLN gene is located at 16p13.3 and encodes for the MSLN mRNA. The pre-pro-mesothelin consists of a signaling peptide at the N-terminus (yellow), mature MPF (blue), furin cleavage …
MSLN Gene - GeneCards | MSLN Protein | MSLN Antibody
Dec 25, 2024 · Complete information for MSLN gene (Protein Coding), Mesothelin, including: function, proteins, disorders, pathways, orthologs, and expression. GeneCards - The Human …
MSLN - Home
The Maine School and Library Network provides internet access, email, web hosting, and other internet related services to almost 1000 schools and libraries across the state of Maine. For …
MSLN mesothelin [Homo sapiens (human)] - Gene - NCBI
Mar 4, 2025 · Title: Effects of hsa-mir-145-5p on the Regulation of msln Expression in Colorectal Adenocarcinoma. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem …
Multiple proteases are involved in mesothelin shedding by cancer …
Dec 1, 2020 · Mesothelin (MSLN) is a lineage restricted cell surface protein expressed in about 30% of human cancers and high MSLN expression is associated with poor survival in several …
Mesothelin as a biomarker for targeted therapy
Aug 23, 2019 · Mesothelin (MSLN), a tumor-associated antigen broadly overexpressed on various malignant tumor cells, while its expression is generally limited to normal mesothelial cells, is …
Biology of Mesothelin and Clinical Implications: A Review of …
Since its discovery in 1992, mesothelin (MSLN) has generated significant interest as a therapeutic target. A number of characteristics make it ideal for this purpose. First, it is not expressed on …
Structures of Cancer Antigen Mesothelin and Its Complexes with ...
Mesothelin (MSLN) was discovered as a cell surface protein normally expressed by mesothelial cells lining the pleura, pericardium, and peritoneum . It is aberrantly expressed in a variety of …
MSLN induced EMT, cancer stem cell traits and ... - ScienceDirect
Apr 30, 2024 · MSLN was a predictor of PDAC mortality, superior to conventional pathologic features as a prognostic marker [[12], [13], [14]]. Additionally, MSLN has been shown to …
Mesothelin-targeted CAR-T cell therapy for solid tumors
Nov 12, 2020 · Lentivirally transduced anti-MSLN CD3ζ/CD28/TLR2 CAR-T cells were found to have superior killing capacity of MSLN-expressing human lung cancer cells compared to …
Correlation of mesothelin (MSLN) expression measured by RNA …
Jan 27, 2025 · MSLN is a cell surface protein expressed in several cancer types, including mesothelioma (MESO), colorectal (CRC), non-small cell lung (NSCLC), ovarian (OVCA), and …
Mesothelin-targeted CAR-T cell therapy for solid tumors
Introduction: Mesothelin (MSLN) is a tumor differentiation antigen normally restricted to the body's mesothelial surfaces, but significantly overexpressed in a broad range of solid tumors. For this …
The antitumor capacity of mesothelin-CAR-T cells in targeting …
Mar 26, 2021 · MSLN-CAR decreased the growth of MSLN-positive tumors concomitant with significantly increased T cells and cytokine levels compared to the control group. These results …
Immunotherapy-based targeting of MSLN - PubMed
Jul 20, 2021 · Targeting of human MSLN + aPFs with two anti-MSLN immunotoxins killed fibroblasts engineered to express human mesothelin and reduced collagen deposition in livers …
Structural elucidation of the mesothelin-mucin-16/CA125 interaction
Aug 8, 2024 · Mesothelin (MSLN) is a cell-surface glycoprotein expressed at low levels on normal mesothelium but overexpressed in many cancers. Mesothelin has been implicated to play …
Application of CAR-T cell therapy targeting mesothelin in
Jul 18, 2024 · Mesothelin (MSLN) is a molecule expressed on the surface of various solid malignant tumor cells that is suitable as a target of tumor cells with high MSLN expression for …
Mesothelin is a target of chimeric antigen receptor T cells for ...
Feb 18, 2019 · Mesothelin (MSLN) has been reported to be expressed in GC tissue and could be targeted by chimeric antigen receptor (CAR) T cells. Mesothelin targeting CAR-T has been …
Immunotherapy-based targeting of MSLN - PubMed Central (PMC)
Mesothelin (Msln) expression is increased in tissue fibroblasts of damaged liver and other organs and Msln is a common mediator of liver, lung, and kidney fibrosis. We show that anti-Msln …